randomization [Study Per­for­mance]

posted by khaoula – Algeria, 2014-06-06 16:04 (3991 d 18:20 ago) – Posting: # 13037
Views: 20,494

Hi everybody , I have a question about impact of randomization in result of bioequivlence study:

we have design of bioequivalence study cross over design with 16 subject (randomised), but at the firt period the 15 suject didn't come, after we collected the results of 15 subjects and we analyzed Kinetica without protocol for the management of dropouts
we had abberants results: for Cmax CV = 0,03 % for hight variable drug, power: 50%, with subject effect and subject/sequence effect

if does not take into account the exclusion of subject N 15 have impact in the result of the study?

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
133 visitors (0 registered, 133 guests [including 9 identified bots]).
Forum time: 10:25 CEST (Europe/Vienna)

Lack of clarity is always a sign of dishonesty.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5